Michele Lamuraglia

Amiens, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Perspectives of positron emission tomography with 2-deoxy-2-fluorine-18-flu-d-glucose (18fdg-pet) in predicting the histological response of high grade epithelial ovarian cancer to neoadjuvant chemotherapy. A primary descriptive study.

Perspectives of positron emission tomography with 2-deoxy-2-fluorine-18-flu-d-glucose (18fdg-pet) in predicting the histological response of high grade epithelial ovarian cancer to neoadjuvant chemotherapy. A primary descriptive study.

Journal: American journal of nuclear medicine and molecular imaging
Published: September 12, 2025

Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.

Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.

Journal: Nature communications
Published: June 04, 2024

Case report: Immunotherapy inducing unexpected overall survival in choroidal melanoma: about a case.

Case report: Immunotherapy inducing unexpected overall survival in choroidal melanoma: about a case.

Journal: Frontiers in oncology
Published: October 12, 2023

Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.

Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.

Journal: Nature communications
Published: December 29, 2022

Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?

Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?

Journal: BMC cancer
Published: December 28, 2021

Molecular Landscape of the Coagulome of Oral Squamous Cell Carcinoma.

Molecular Landscape of the Coagulome of Oral Squamous Cell Carcinoma.

Journal: Cancers
Published: December 17, 2021

Survival of Patients with Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small Cell Lung Cancer Treated beyond the Second Line in the Tyrosine Kinase Inhibitor Era.

Survival of Patients with Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small Cell Lung Cancer Treated beyond the Second Line in the Tyrosine Kinase Inhibitor Era.

Journal: Cancers
Published: July 07, 2021

Non-Invasive Ultrasonic Description of Tumor Evolution.

Non-Invasive Ultrasonic Description of Tumor Evolution.

Journal: Cancers
Published: June 19, 2021

DNA damage response- and JAK-dependent regulation of PD-L1 expression in head and neck squamous cell carcinoma (HNSCC) cells exposed to 5-fluorouracil (5-FU).

DNA damage response- and JAK-dependent regulation of PD-L1 expression in head and neck squamous cell carcinoma (HNSCC) cells exposed to 5-fluorouracil (5-FU).

Journal: Translational oncology
Published: January 22, 2021

PARP inhibition in treatment of pancreatic cancer.

PARP inhibition in treatment of pancreatic cancer.

Journal: Expert review of anticancer therapy
Published: September 16, 2020

Glioblastoma and bevacizumab in elderly patients: Monocentric study.

Glioblastoma and bevacizumab in elderly patients: Monocentric study.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: July 15, 2020

Monitoring Dual VEGF Inhibition in Human Pancreatic Tumor Xenografts With Dynamic Contrast-Enhanced Ultrasound.

Monitoring Dual VEGF Inhibition in Human Pancreatic Tumor Xenografts With Dynamic Contrast-Enhanced Ultrasound.

Journal: Technology in cancer research & treatment
Published: February 18, 2020
Showing 1-12 of 26

Last Updated: 09/26/2026